Archive: 23/05/2016

End of the road for aliskiren in heart failure

A subgroup analysis in heart failure patients with diabetes from the ATMOSPHERE trial has failed to show benefit and signals the end of the road for aliskiren in heart failure. The findings were presented for the first time ...

page 6 from 8